Astroglioma

1 clinical trials · Condition

Record	Firm	Date
Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma (NCT02942264)	National Cancer Institute (NCI)	2016-12-14

Every clearance here is in the API, with alerts when new ones post.